4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-090468
Chief Executive Officer sold 2,788 shares at $9.25 ($25,789)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2020-08-03 | Sale | −2,788 | $9.25 | $25,789 | 3,064 | D: show line 1 in the form |
| Open-market sales · 2,788 sh · avg $9.25 · $25,789 | |||||||
Loading xslF345X03/a4.xml…